Chen X. 2006. Biochemical properties of recombinant prolyl dipeptidases DPP-IV and DPP8. Adv. Exp. Med. Biol. 575: 27–32. doi:10.1007/0-387-32824-6_3. PMID16700505
Masur K; i dr. 2006. DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells. Regul Pept. 137 (3): 147–55. doi:10.1016/j.regpep.2006.07.003. PMID16908079Eksplicitna upotreba et al. u: |author= (pomoć)
Wesley UV; i dr. 2005. Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway. Cancer Res. 65 (4): 1325–34. doi:10.1158/0008-5472.CAN-04-1852. PMID15735018Eksplicitna upotreba et al. u: |author= (pomoć)
Chen X. 2006. Biochemical properties of recombinant prolyl dipeptidases DPP-IV and DPP8. Adv. Exp. Med. Biol. 575: 27–32. doi:10.1007/0-387-32824-6_3. PMID16700505
Pro B, Dang N. 2004. CD26/dipeptidyl peptidase IV and its role in cancer. Histol Histopathol. 19 (4): 1345–51. PMID15375776
Masur K; i dr. 2006. DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells. Regul Pept. 137 (3): 147–55. doi:10.1016/j.regpep.2006.07.003. PMID16908079Eksplicitna upotreba et al. u: |author= (pomoć)
Wesley UV; i dr. 2005. Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway. Cancer Res. 65 (4): 1325–34. doi:10.1158/0008-5472.CAN-04-1852. PMID15735018Eksplicitna upotreba et al. u: |author= (pomoć)